Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may of…
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
Officials and experts continue to monitor developments closely as the situation unfolds. Communities affected by the story are watching for further updates in the days ahead. Analysts say the implications could extend well beyond the immediate headlines, with policymakers and industry leaders expected to respond in the coming weeks.
Readers following this story should check back for the latest details as new information becomes available.
